Related Experiment Videos
Conversion of leumorphin (dynorphin B-29) to dynorphin B and dynorphin B-14 by thiol protease activity
Abstract:
Dynorphin B (rimorphin) is formed from leumorphin (dynorphin B-29) by the action of a thiol protease from rat brain membranes, in a single step. This represents a "single-arginine cleavage" between threonine-13 and arginine-14 of the substrate. We have observed that in addition to dynorphin B, dynorphin B-14 is formed from dynorphin B-29. Among the various protease inhibitors tested, none except p-chloromercuribenzensulfonic acid inhibited the formation of the two products. Both temperature and pH had similar effects on the formation of dynorphin B-14 and dynorphin B. The inhibitory potencies of adrenocorticotropic hormone, peptide E, and dynorphin A were virtually identical for the formation of the two products. These results suggest that the same enzyme may be responsible for the formation of dynorphin B-14 and dynorphin B.
Insights
A thiol protease in rat brain membranes cleaves leumorphin (dynorphin B-29) to form dynorphin B and dynorphin B-14. Similar effects of inhibitors, pH, and temperature suggest a single enzyme is responsible for both products.
Area of Science:
- Neuroscience
- Biochemistry
- Enzymology
Background:
- Dynorphin B (rimorphin) is a biologically active peptide derived from larger precursors.
- Leumorphin (dynorphin B-29) serves as a direct precursor to dynorphin B.
- The enzymatic processing of leumorphin is crucial for generating functional dynorphin peptides.
Purpose of the Study:
- To investigate the enzymatic mechanism of dynorphin B formation from leumorphin.
- To identify the specific cleavage site and the enzyme involved in this process.
- To characterize the properties of the protease responsible for dynorphin B generation.
Main Methods:
- Incubation of leumorphin (dynorphin B-29) with rat brain membrane preparations.
- Analysis of peptide products using protease inhibitors and varying pH and temperature conditions.
- Comparative assessment of the effects of different peptide inhibitors on product formation.
Main Results:
- Leumorphin (dynorphin B-29) is converted to dynorphin B and dynorphin B-14 by a rat brain membrane thiol protease.
- The cleavage occurs at the single-arginine site between threonine-13 and arginine-14.
- p-Chloromercuribenzensulfonic acid inhibited product formation, while other protease inhibitors showed similar potencies against both products.
- Temperature and pH affected the formation of dynorphin B-14 and dynorphin B similarly.
Conclusions:
- The findings strongly suggest that a single thiol protease enzyme is responsible for the formation of both dynorphin B and dynorphin B-14 from leumorphin.
- This enzyme performs a specific single-arginine cleavage within the precursor peptide.
- Understanding this enzymatic pathway provides insights into opioid peptide processing in the brain.